# 0641-0121-25 · Hydromorphone Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc. — FDA drug shortage duration tracker

For 0641-0121-25 · Hydromorphone Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc., package ndc is 0641-0121-25; generic name is Hydromorphone Hydrochloride Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-08.

- **Package NDC:** 0641-0121-25 _(verified: appears in the quote below)_
- **Generic name:** Hydromorphone Hydrochloride Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hikma Pharmaceuticals USA, Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **FDA note:** Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. _(verified: appears in the quote below)_
- **Initial posting date:** 11/03/2017 _(verified: appears in the quote below)_
- **Last update date:** 08/13/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3224 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Analgesia/Addiction _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "11/03/2017", "change_date": "01/03/2025", "package_ndc": "0641-0121-25", "generic_name": "Hydromorphone Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released."

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"

### Status

> "update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"

### Last update date

> "update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"

### Dosage form

> "update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"

### Therapeutic category

> "update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-08. Review by: 2026-09-11.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).